Research programme: vitamin D 1-hydroxylase inhibitors - OPKO Health
Alternative Names: Vitamin D 1-hydroxylase inhibitors research programme - CytochromaLatest Information Update: 23 Apr 2014
At a glance
- Originator Cytochroma
- Class
- Mechanism of Action Calcidiol 1-monooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypercalcaemia; Sarcoidosis
Most Recent Events
- 04 Mar 2013 Cytochroma has been acquired by OPKO Health
- 16 Dec 2002 Discontinued - Preclinical for Hypercalcaemia in Canada (unspecified route)
- 16 Dec 2002 Discontinued - Preclinical for Sarcoidosis in Canada (unspecified route)